Literature DB >> 11111181

Extracorporal shock wave therapy in the treatment of Peyronie's disease. First results of a case-controlled approach.

E W Hauck1, B M Altinkilic, M Ludwig, G Lüdecke, I Schroeder-Printzen, C Arens, W Weidner.   

Abstract

OBJECTIVE: To test whether extracorporal shock wave therapy (ESWT) has an effect in the treatment of Peyronie's disease.
METHODS: 22 patients with Peyronie's disease and previous unsuccessful oral drug therapy were treated with ESWT in a prospective design with a follow-up of at least 3 months; 23 age-matched patients without previous therapy received oral placebo drug for 6 months daily as control. The standard follow-up included palpation, ultrasound, autophotography and evaluation of symptomatology based on a symptom score. The shock waves were applied under ultrasound guidance using the 'Storz Minilith SL1' lithotripter.
RESULTS: The results show a significant decrease in penile curvature in the patients treated with ESWT. Concerning the decrease in pain, subjective improvement and improvement in the quality of sexual intercourse, there was no significant difference to the case-control group. The inhomogeneity of the 2 groups may influence these results due to the questionable varying natural history.
CONCLUSIONS: A prospective, controlled multicenter study with standardized parameters (concerning technique and patients) is urgently required to test the effect of ESWT.

Entities:  

Mesh:

Year:  2000        PMID: 11111181     DOI: 10.1159/000020359

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  6 in total

1.  [Significance of extracorporeal shock-wave therapy (ESWT) in plastic penile induration. Statement of the DGU].

Authors:  W Weidner; E W Hauck
Journal:  Urologe A       Date:  2004-05       Impact factor: 0.639

2.  Peyronie's Disease: Nonsurgical Therapy Options.

Authors:  Franklin E Kuehhas; Peter Weibl; Tosev Georgi; Nenad Djakovic; Ralf Herwig
Journal:  Rev Urol       Date:  2011

Review 3.  Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain.

Authors:  Grzegorz Lukasz Fojecki; Stefan Tiessen; Palle Jörn Sloth Osther
Journal:  World J Urol       Date:  2016-04-23       Impact factor: 4.226

Review 4.  A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease.

Authors:  L Gao; S Qian; Z Tang; J Li; J Yuan
Journal:  Int J Impot Res       Date:  2016-06-02       Impact factor: 2.896

Review 5.  Conservative management options for Peyronie's disease.

Authors:  Gregory S Jack; Nestor Gonzalez-Cadavid; Jacob Rajfer
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

Review 6.  Peyronie's disease and low intensity shock wave therapy: Clinical outcomes and patient satisfaction rate in an open-label single arm prospective study in Australian men.

Authors:  Eric Chung
Journal:  Korean J Urol       Date:  2015-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.